A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Calcific tendinitis of the shoulder is a relatively common condition with numerous treatment options. Here, we discuss the indications of focused shock waves generated by a single-crystal piezoelectric device, describe a treatment protocol, and present the preliminary results.
Focused shock waves have emerged as a highly effective noninvasive therapeutic option for the treatment of calcific tendinitis of the shoulder. There are three types of focused shock wave generators: electrohydraulic, electromagnetic, and piezoelectric. According to our literature search, there are no reports of results with the use of single-crystal piezoelectric generators in calcific tendinitis of the shoulder. In a consecutive retrospective series of 23 patients with Gärtner type I and II calcifications of the rotator cuff, we performed three applications of high-energy piezoelectric focused waves (4,000 pulses per session with a frequency of 6 Hz). At the final follow-up (average of 14 months), 82.6% of the cases showed complete resorption of the calcification in radiographic controls. In 8.7% of the cases, partial disappearance of the calcification was achieved, and in the remaining 8.7% there were no significant changes. Single-crystal piezoelectric generators have a success rate comparable to those already reported with electrohydraulic and electromagnetic devices.
Calcium crystal deposits can appear in different regions of the musculoskeletal system, but their most frequent location is in the shoulder region. Gondos1 reported that 69% of calcification cases occur in the shoulder location. Calcific shoulder tendinopathies are characterized by the presence of hydroxyapatite deposits in the rotator cuff tendons. It is estimated that the prevalence in the general population ranges from 2.7% to 20%2.
Calcific tendinitis of the shoulder typically affects patients between 30 to 60 years old2. It is also more frequent in women (57%-76.7%) with respect to men3. The location of the calcium deposit is much more frequent in the distal tendon of the supraspinatus muscle4, while localizations in the infraspinatus, teres minor, subscapularis, and long head of the biceps have also been reported4.
Women between 30 and 60 years old, with a calcification over 1.5 cm in length, have the highest chance of being symptomatic5. Although it tends to spontaneously resolve itself, the cycle can often be halted. In these cases, symptoms of pain and disability appear, and it is necessary to take active therapeutic action.
Gärtner's radiological classification6 differentiates three types of images. In type I, the image is dense, with well-defined borders corresponding to the formative phase. In the type II image, the appearance is mixed, with a deposit that can be dense but with diffuse borders, or transparent with well-defined borders. Finally, type III, characteristic of the resorptive phase, presents a transparent deposit with diffuse borders. Active therapeutic action, including shock wave applications, ultrasound-guided interventions, or surgery, must be taken in Gärtner type I and II, since in type III cases, the chance of short-term spontaneous resorption is very high6.
Conservative treatment is initially preferred. This classically includes rest, analgesics, non-steroidal and steroidal anti-inflammatory drugs, rehabilitation, and local injections. Good results of conservative treatment have been shown, especially in the resorptive stage, but a failure of conservative treatment has been reported in 27% to 39% of cases7,8,9. Several prognostic factors have been recognized as having a significant influence on the results of conservative treatment7,8. The location on both shoulders, the presence of a large-volume deposit, the location of the calcification in the anterior region of the acromion, and the spread of the deposit medially beyond the level of the acromioclavicular joint, are factors of poor prognosis7,8. A Gärtner stage III calcification and lack of sonographic extinction of the calcific deposit are considered predictors of good prognosis for conservative treatment7.
When conservative treatment fails, many patients end up becoming chronic carriers of shoulder pain with similar clinical characteristics to chronic rotator cuff non-calcific tendinopathies. The usual alternative to conservative treatment failure was surgery. Gschwend10 formulated three precise surgical indications for rotator cuff calcifications: symptom progression, constant and unmanageable pain, and failure of conservative treatment. Surgical treatment can be performed open or arthroscopically. Although open treatment was historically performed with good results11, arthroscopic techniques have gained popularity12,13. Musculoskeletal ultrasound and ultrasound-guided interventions (UGI) have significantly developed and been used in clinical practice in recent years14,15,16.
Extracorporeal shock wave treatment (ESWT) has emerged as an effective option prior to invasive procedures when conservative treatment has failed. Its therapeutic effect is not just mechanical, but based on mechanotransduction, a phenomenon by which cells can recognize a mechanical stimulus and react biologically17. However, shock wave treatment has limitations. Unlike lithotripsy, in which we only depend on the mechanical effect of the waves, there must also be a biological response by the patient. This response does not always occur.
The generic term "extracorporeal shock waves" includes two different technologies: focused shock waves and radial pressure waves17,18,19. The two technologies have therapeutic efficacy but differ in their physical characteristics and indications. Focused shock waves have a wide frequency range (from approximately 150 kHz up to 100 MHz), large pressure amplitude (up to 150 MPa) with a short rise time and small pulse width, followed by a low-stress wave (up to -25 MPa)18,19. Focused shock waves are generated by electrohydraulic, electromagnetic, and piezoelectric sources17,18,19.
Radial pressure waves are sound waves with pressure peaks of up to 30 MPa and much higher rise times than focused shock waves (about 3 µs)18,19. Radial pressure waves are generated by accelerating a projectile inside a cylindrical guiding tube by compressed air. The projectile hits an applicator at the end of the tube and produces a radial pressure wave that expands into the target tissue17,18,19.
Focused shock waves have a grade "A" recommendation for the treatment of rotator cuff calcifications17. This means that there is high-quality scientific evidence supported by level I studies with consistent findings. In the case of radial waves, the level of recommendation for rotator cuff calcifications is "I". This means that the evidence is insufficient to make a recommendation17.
Therapeutical efficacy of focused shock waves in calcific tendinopathies of the shoulder has been compared with open20 and arthroscopic21 surgery, with comparable results. However, shock waves have less frequent and less severe complications20,21, and the method is also cost-effective. Haake22 reported a significant difference between surgical costs (€13,400-23,450) and those of focused shock waves (€2,700-4,300). His results match with other studies that have shown a five- to sevenfold decrease in the cost of shock wave treatment compared to arthroscopic surgery23,24. There are also studies in which shock waves have been compared with ultrasound-guided interventions with controversial results15,25. Several publications4,17,26,27,28,29,30,31,32,33 have reported that a high level of energy is more effective when treating calcific tendinitis of the shoulder. Verstraelen27 reported that the use of high energy determines a higher rate of calcific resorption in a level I evidence study. This is a clear advantage for focused devices over radial ones because they can generate higher levels of energy. Numerous studies have reported good results with electrohydraulic4,17,34,35 and electromagnetic4,17,36,37,38 focused devices. A report has also been published using a multi-crystal piezoelectric device to treat rotator cuff calcifications39. We are not aware of any reports publishing the technique and results of single-crystal piezoelectric devices as of yet.
This report aims to describe the treatment protocol using a single-crystal piezoelectric device and to report the preliminary results.
The protocol follows the guidelines of the Buenos Aires British Hospital's human research ethics committee.
1. Patient evaluation
2. Application technique
Figure 1: Applicator and coupling pad variations. Three different sizes of coupling pads are available. Each one allows the focus to be taken to a different depth in the tissues. Please click here to view a larger version of this figure.
Figure 2: Applicator positioning. Focused wave application in the supraspinatus tendon. Please click here to view a larger version of this figure.
3. Post-treatment protocol
A retrospective study of a series of patients with shoulder pain due to calcium deposits in the rotator cuff tendons was carried out in our institution. The inclusion criteria were Gärtner stage I and II calcifications and at least 3 months of previous conservative treatment without satisfactory results. Patients with Gärtner III calcifications, other associated pathology in the affected shoulder, previous local cortisone injection, and a history of surgery in the affected shoulder were excluded.
This study shows encouraging results with the application of focused shock waves generated by a single-crystal piezoelectric device in a series of retrospectively evaluated patients with calcific tendinitis of the shoulder. According to the bibliographic search we carried out, this is the first study that reports results with a single-crystal piezoelectric device. Recently, Louwerens39 published a study using a piezoelectric shock wave device for the treatment of rotator cuff calcifications. Howev...
None
None
Name | Company | Catalog Number | Comments |
BTL 6000 FSWT | BTL | 09400B001107 | Focused Shock Wave Piezoelectric Source |
Ultrasound & SWT Gel 300 mL | BTL | 237-GEL102 | Alcohol free hypoallergic gel |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved